NCTY The9 Limited

Ordinary Share

(Title of Class of Securities)

88337K104**

(CUSIP Number)

EXPLANATORY NOTE

This Amendment No. 1 (“Amendment No. 1”) amends the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) by each of the Reporting Persons on December 21, 2015 related to the ordinary shares, $0.01 par value per share (“Ordinary Shares”), of the Issuer. Except as specifically provided herein, this Amendment No. 1 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used herein shall have the meaning ascribed to them in the Schedule 13D, unless otherwise defined herein.

Item 3. Source and Amount of Funds or Other Consideration

Item 3 is hereby amended and supplemented by the following:

The information set forth in or incorporated by reference in Item 2 of the Schedule 13D and Item 5 of this Amendment No. 1 is incorporated by reference in its entirety into this Item 3.

On June 7, 2017, APSOF entered into a definitive Share Purchase Agreement (the “Share Purchase Agreement”) with the Issuer and on June 8, 2017 was issued 12,500,000 Ordinary Shares in a private placement for a price per Ordinary Share of US$1.20 for which the aggregate consideration of approximately US$15,000,000 (the “Consideration”) has not yet been paid subject to the fulfillment of certain conditions as further described in the Share Purchase Agreement included as Exhibit 99.13 to this Amendment No. 1. The foregoing description of the Share Purchase Agreement is not intended to be complete and is qualified in its entirety by reference to the full text of the Share Purchase Agreement, a copy of which is attached hereto as Exhibit 99.13 and is incorporated herein by reference. No funds were used to acquire the beneficial ownership of the Shares issued pursuant to the Share Purchase Agreement; the Consideration will be paid in full on the Closing (as defined in the Share Purchase Agreement) out of the working capital of APSOF.

Item 5. Interest in Securities of the Issuer

Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

(a) The aggregate number of Ordinary Shares and the percentage of total outstanding Ordinary Shares beneficially owned by each of the Reporting Persons is set forth below. References to percentage ownerships of Ordinary Shares in this Amendment No. 1 are based upon the 107,633,755 Ordinary Shares outstanding as of June 8, 2017 based on information provided to the Reporting Persons by the Issuer.

APSOF beneficially owns an aggregate of 37,849,826 Ordinary Shares consisting of (i) 20,570,982 ADSs issuable upon conversion of the Convertible Notes and 4,778,844 ADSs issuable upon exercise of the Warrants in each case held by the Investor and issuable within 60 days of the date of this Schedule 13D (the “Conversion Shares”), and (ii) 12,500,000 Ordinary Shares issued in a private placement to APSOF pursuant to the Share Purchase Agreement (together with the Conversion Shares, the “Shares”). APSOF, as the direct parent company of the Investor, may be deemed to beneficially own the Conversion Shares.

The Investor beneficially owns an aggregate of 25,349,826 Ordinary Shares consisting of the Conversion Shares.

APIML is the general partner of APSOF and by virtue of that relationship has indirect but controlling authority over the Investor and may be deemed to beneficially own all of the Shares.

Ng Chi Keung Kenneth as a director of APIML, in such capacity, possesses ultimate decision making power of APIML, APSOF, and the Investor with respect to the voting and disposition of securities beneficially owned thereby and as a result may also be deemed to beneficially own all of the Shares.

(b) Each of Ng Chi Keung Kenneth, APIML and APSOF may be deemed to have shared power to vote and dispose or direct the vote and direct the disposition of all of the Shares. The Investor may be deemed to have shared power to vote and dispose or direct the vote and direct the disposition of the Conversion Shares.

(c) Except for the transactions reported herein, there have been no transactions in the securities of the Issuer effected by any Reporting Person within the last 60 days.

(d) Under the terms of the Participation Agreements, each Participant may be deemed to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Issued Securities or any ADSs issued upon conversion or exercise thereof. Based on the amount of their respective Participations, Quality Event Limited and APSOF may each be deemed to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than five percent of the outstanding ADSs of the Issuer. Except as set forth in the immediately preceding sentences in this Item 5(d), no other person (other than the Reporting Persons) is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities covered by this Schedule 13D.

(e) Not applicable.

Item 7. Material to be Filed as Exhibits

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the General Rules and Regulations of the Securities and Exchange Act of 1934, as amended, the undersigned agree that the attached statement is filed on behalf of each of them.

Dated July 21, 2017